IGF-I receptor phosphorylation is impaired in cathepsin X-deficient prostate cancer cells

Biological Chemistry

Volumn 393, Issue 12, 2012, Pages 1457-1462

  Kraus, Steffen ^a   Fruth, Maximilian ^a   Bunsen, Thea ^a   Naler, Dorit K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Growth factor; LNCaP; PC 3; Protease; RNA interference; Senescence

Indexed keywords

CATHEPSIN X; MESSENGER RNA; SOMATOMEDIN B; SOMATOMEDIN C RECEPTOR;

BINDING AFFINITY; CANCER CELL CULTURE; CARCINOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

CATHEPSIN Z; CATHEPSINS; CELL AGING; CELL LINE, TUMOR; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MALE; PHOSPHORYLATION; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN PRECURSORS; RECEPTOR, IGF TYPE 1; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84869478113     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2012-0209     Document Type: Conference Paper

References (28)

1. Andersson, S., D'Arcy, P., Larsson, O., and Sehat, B. (2009). Focal adhesion kinase (FAK) activates and stabilizes IGF-1 receptor. Biochem. Biophys. Res. Commun. 387, 36-41.
2. Beattie, J., McIntosh, L., and van der Walle, C.F. (2010). Cross-talk between the insulin-like growth factor (IGF) axis and membrane integrins to regulate cell physiology. J. Cell. Physiol. 224, 605-611.
3. Campisi, J. (2001). Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 11, S27-S31.
4. Chen, K.L., Chang, W.S., Cheung, C.H., Lin, C.C., Huang, C.C., Yang, Y.N., Kuo, C.P., Kuo, C.C., Chang, Y.H., Liu, K.J., et al. (2012). Targeting cathepsin S induces tumor cell autophagy via the EGFR-ERK signaling pathway. Cancer Lett. 317, 89-98.
5. Ellis, M.J., Leav, B.A., Yang, Z., Rasmussen, A., Pearce, A., Zweibel, J.A., Lippman, M.E., and Cullen, K.J. (1996). Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells. Mol. Endocrinol. 10, 286-297.
6. Girish, V. and Vijayalakshmi, A. (2004). Affordable image analysis using NIH Image/ImageJ. Indian J. Cancer 41, 47.
7. Gruber, H.E., Hoelscher, G.L., Ingram, J.A., Bethea, S., and Hanley, E.N. (2008). IGF-1 rescues human intervertebral annulus cells from in vitro stress-induced premature senescence. Growth Factors 26, 220-225.
8. Hanahan, D. and Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100, 57-70.
9. Jevnikar, Z., Obermajer, N., Doljak, B., Turk, S., Gobec, S., Svajger, U., Hailfinger, S., Thome, M., and Kos, J. (2011). Cathepsin X cleavage of the β2 integrin regulates talin-binding and LFA-1 affinity in T cells. J. Leukoc. Biol. 90, 99-109.
10. Kamrava, M., Gius, D., Casagrande, G., and Kohn, E. (2011). Will targeting insulin growth factor help us or hurt us?: an oncologist's perspective. Ageing Res. Rev. 10, 62-70.
11. Kanzaki, Y., Onoue, F., Ishikawa, F., and Ide, T. (2002). Telomerase rescues the expression levels of keratinocyte growth factor and insulin-like growth factor-II in senescent human fibroblasts. Exp. Cell Res. 279, 321-329.
12. Kobayashi, S., Kamino, Y., Hiratsuka, K., Kiyama-Kishikawa, M., and Abiko, Y. (2004). Age-related changes in IGF-1 expression in submandibular glands of senescence-accelerated mice. J. Oral Sci. 46, 119-125.
13. Kraus, S., Bunsen, T., Schuster, S., Cichon, M.A., Tacke, M., Reinheckel, T., Sommerhoff, C.P., Jochum, M., and Nägler, D.K. (2011). Cellular senescence induced by cathepsin X dow. Eur. J. Cell Biol. 90, 678-686.
14. Krueckl, S.L., Sikes, R.A., Edlund, N.M., Bell, R.H., Hurtado-Coll, A., Fazli, L., Gleave, M.E., and Cox, M.E. (2004). Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model. Cancer Res. 64, 8620-8629.
15. Krueger, S., Kalinski, T., Hundertmark, T., Wex, T., Kuster, D., Peitz, U., Ebert, M., N ä gler, D.K., Kellner, U., Malfertheiner, P., et al. (2005). Up-regulation of cathepsin X in Helicobacter pylori gastritis and gastric cancer. J. Pathol. 207, 32-42.
16. Lechner, A.M., Assfalg-Machleidt, I., Zahler, S., Stoeckelhuber, M., Machleidt, W., Jochum, M., and Nägler, D.K. (2006). RGD-dependent binding of procathepsin X to integrin αvβ3 mediates cell-adhesive properties. J. Biol. Chem. 281, 39588-39597.
17. Liu, W., Bloom, D.A., Cance, W.G., Kurenova, E.V., Golubovskaya, V.M., and Hochwald, S.N. (2008). FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells. Carcinogenesis 29, 1096-1107.
18. Malla, R., Gopinath, S., Alapati, K., Gondi, C.S., Gujrati, M., Dinh, D.H., Mohanam, S., and Rao, J.S. (2010). Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas. PLoS One 5, e13731.
19. Metalli, D., Lovat, F., Tripodi, F., Genua, M., Xu, S.Q., Spinelli, M., Alberghina, L., Vanoni, M., Baffa, R., Gomella, L.G., et al. (2010). The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt-and mitogen-activated protein kinase-dependent activation of paxillin. Am. J. Pathol. 176, 2997-3006.
20. Nägler, D.K., Kruger, S., Kellner, A., Ziomek, E., Menard, R., Buhtz, P., Krams, M., Roessner, A., and Kellner, U. (2004). Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia. Prostate 60, 109-119.
21. Navab, R., Pedraza, C., Fallavollita, L., Wang, N., Chevet, E., Auguste, P., Jenna, S., You, Z., Bikfalvi, A., Hu, J., et al. (2008). Loss of responsiveness to IGF-I in cells with reduced cathepsin L expression levels. Oncogene 27, 4973-4985.
22. Pandini, G., Mineo, R., Frasca, F., Roberts, C.T. Jr., Marcelli, M., Vigneri, R., and Belfiore, A. (2005). Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells. Cancer Res. 65, 1849-1857.
23. Pollak, M. (2008). Insulin and insulin-like growth factor signalling in neoplasia. Nat. Rev. Cancer 8, 915-928.
24. Sevenich, L., Schurigt, U., Sachse, K., Gajda, M., Werner, F., Muller, S., Vasiljeva, O., Schwinde, A., Klemm, N., Deussing, J., et al. (2010). Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice. Proc. Natl. Acad. Sci. USA 107, 2497-2502.
25. Smith, S.K. and Kipling, D. (2004). The role of replicative senescence in cancer and human ageing: utility (or otherwise) of murine models. Cytogenet. Genome Res. 105, 455-463.
26. Ucar, D.A., Cox, A., He, D.H., Ostrov, D.A., Kurenova, E., and Hochwald, S.N. (2011). A novel small molecule inhibitor of FAK and IGF-1R protein interactions decreases growth of human esophageal carcinoma. Anticancer Agents Med. Chem. 11, 629-637.
27. Vasiljeva, O., Papazoglou, A., Kruger, A., Brodoefel, H., Korovin, M., Deussing, J., Augustin, N., Nielsen, B.S., Almholt, K., Bogyo, M., et al. (2006). Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Cancer Res. 66, 5242-5250.
28. Wang, J., Chen, L., Li, Y., and Guan, X.Y. (2011). Overexpression of cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. PLoS One 6, e24967.